Introduction
Bovine Pregnancy-Associated Glycoproteins (bPAGs) are aspartic peptidases primarily secreted by the binucleate trophoblast cells of the ruminant placenta.   Their presence in maternal blood serum serves as a highly specific biomarker for pregnancy detection and monitoring in cattle.

Key Features
​​High Specificity:​​ Specifically targets epitopes unique to bovine PAG isoforms, ensuring minimal cross-reactivity with non-target proteins.

​​High Affinity:​​ Demonstrates strong binding affinity for bPAGs, enabling sensitive detection in complex biological samples (e.g., serum, plasma, milk).

​​Validated Performance:​​ Rigorously tested for use in ELISA, Western Blotting, Immunohistochemistry (placental tissue), and rapid diagnostic test formats.

​​Reliable & Reproducible:​​ Manufactured under stringent quality control to ensure batch-to-batch consistency.

Intended Use
This Anti-Bovine PAG Antibody is intended for research use only (RUO) and in vitro diagnostic (IVD) applications for the detection and quantification of bovine Pregnancy-Associated Glycoproteins.   Its primary applications include:

​​Early Pregnancy Diagnosis:​​ Detection of bPAGs in maternal serum or milk as early as 28 days post-breeding.

​​Pregnancy Confirmation & Monitoring:​​ Quantitative assessment of bPAG levels throughout gestation.

​​Placental Function Studies:​​ Investigation of trophoblast cell biology and placental development in cattle.

​​Development of Diagnostic Kits:​​ Essential component for ELISA kits, lateral flow immunoassays (LFIA), and other immunoassays targeting bPAGs.

Target Information
​​Target:​​ Bovine Pregnancy-Associated Glycoproteins (bPAGs)

Shenzhen AccuSift Biotechnology Co., Ltd. (referred to as AccuSift) was established in January 2014. It is a technology-oriented enterprise specializing in the preparation of antigens and antibodies for IVD raw materials and food safety raw materials, as well as the development and application of biotechnology. The company has an advanced and complete production platform for single and polyclonal antibodies and has prepared a variety of small molecule hapten related to IVD raw materials, pesticides and veterinary drugs, antibiotics, mycotoxins, hormones, heavy metals, pigments, etc., and high-quality monoclonal antibodies. The company provides comprehensive antibody services, antigen design, synthesis, antibody preparation and labeling, and immunological experiments for domestic and foreign users. The company's antibody research and development department has high-quality talents, strong research and development capabilities and a quality assurance system, providing high-precision and high-stability product solutions for clinical diagnosis and food safety detection.

AccuSift adheres to the business philosophy of "integrity, innovation and progress", with the mission of "focusing on the source of precision and safeguarding the beauty of health", providing strong support for researchers in the fields of clinical diagnosis and food safety.